Target Ferritin in CKD Stage 3a
For patients with CKD stage 3a, maintain serum ferritin ≥100 ng/mL and transferrin saturation (TSAT) ≥20% to ensure adequate iron stores for erythropoiesis. 1
Minimum Thresholds
The NKF-K/DOQI guidelines establish clear minimum targets for all CKD patients:
- Serum ferritin: ≥100 ng/mL
- TSAT: ≥20%
These thresholds apply universally across CKD stages, including stage 3a, and represent the minimum levels needed to prevent iron deficiency and support adequate hemoglobin production 1.
Upper Safety Limits
While maintaining adequate iron stores, avoid chronically exceeding:
- Serum ferritin: 800 ng/mL
- TSAT: 50%
The guidelines emphasize that ferritin levels between 300-800 ng/mL have been common in dialysis patients without evidence of adverse iron-mediated effects 1. However, there is no physiologic rationale for maintaining levels above these upper thresholds.
Key Clinical Considerations
The goal is optimizing erythropoiesis, not achieving specific ferritin numbers. 1 Many patients remain functionally iron deficient even with ferritin ≥100 ng/mL and TSAT ≥20%, particularly those requiring erythropoiesis-stimulating agents (ESAs). In these cases, additional iron supplementation is warranted as long as it doesn't chronically maintain ferritin >800 ng/mL or TSAT >50% 1.
Distinguishing Absolute vs. Functional Iron Deficiency
- Absolute iron deficiency: Ferritin <100 ng/mL AND TSAT <20% 1
- Functional iron deficiency: TSAT <20% with ferritin ≥100 ng/mL (adequate stores but insufficient iron release for erythropoiesis) 1
Important Caveat: Inflammation
Ferritin is an acute-phase reactant and can be falsely elevated during inflammation 1. When ferritin is 100-700 ng/mL with TSAT <20%, distinguish between functional iron deficiency (serial ferritin decreases during ESA therapy but remains >100 ng/mL) versus inflammatory iron block (abrupt ferritin increase with sudden TSAT drop) 1.
Monitoring Frequency
For CKD stage 3a patients:
- Not on ESA therapy: Monitor TSAT and ferritin every 3-6 months 1
- On ESA therapy: Monitor monthly during dose titration, then every 3 months once stable 1
Iron Supplementation Strategy for CKD Stage 3a
When ferritin <100 ng/mL and/or TSAT <20%:
- First-line: Trial of oral iron (200 mg elemental iron daily for adults) for 1-3 months 1
- If oral iron fails or not tolerated: Consider IV iron 500-1,000 mg as single infusion, repeated as needed 1
Note: CKD stage 3a patients (non-dialysis) may not maintain adequate iron status with oral iron alone, particularly if receiving ESA therapy 1. Most will eventually require IV iron for optimal management.